GOLDMAN SACHS GROUP INC - UTAH MED PRODS INC ownership

UTAH MED PRODS INC's ticker is UTMD and the CUSIP is 917488108. A total of 85 filers reported holding UTAH MED PRODS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of UTAH MED PRODS INC
ValueSharesWeighting
Q3 2023$3,522,216
-7.5%
40,956
+0.2%
0.00%0.0%
Q2 2023$3,807,779
-7.5%
40,856
-6.0%
0.00%0.0%
Q1 2023$4,118,705
-0.1%
43,460
+6.0%
0.00%0.0%
Q4 2022$4,121,227
+17.9%
40,995
+0.0%
0.00%0.0%
Q3 2022$3,497,000
+32.4%
40,990
+33.3%
0.00%0.0%
Q2 2022$2,642,000
+0.3%
30,758
+5.0%
0.00%0.0%
Q1 2022$2,633,000
-21.0%
29,301
-12.1%
0.00%0.0%
Q4 2021$3,332,000
+4.5%
33,320
-3.0%
0.00%0.0%
Q3 2021$3,190,000
+9.2%
34,3630.0%0.00%0.0%
Q2 2021$2,922,000
+1.0%
34,363
+2.8%
0.00%0.0%
Q1 2021$2,894,000
+49.3%
33,420
+45.3%
0.00%
Q4 2020$1,938,000
+43.0%
22,993
+35.5%
0.00%
Q3 2020$1,355,000
+515.9%
16,968
+584.5%
0.00%
Q2 2020$220,000
-6.4%
2,479
-0.8%
0.00%
Q1 2020$235,000
-47.5%
2,500
-39.8%
0.00%
Q4 2019$448,000
+107.4%
4,154
+84.6%
0.00%
Q3 2019$216,000
+0.9%
2,250
+0.8%
0.00%
Q2 2019$214,000
-10.8%
2,232
-12.4%
0.00%
Q3 2018$240,000
-10.4%
2,548
+4.8%
0.00%
Q2 2018$268,000
-1.8%
2,431
-44.5%
0.00%
Q1 2017$273,0004,3770.00%
Other shareholders
UTAH MED PRODS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Clean Yield Group 49,094$3,535,0001.48%
MORGAN DEMPSEY CAPITAL MANAGEMENT LLC 27,464$1,988,0000.72%
Ativo Capital Management LLC 16,525$1,196,0000.33%
Ancora Advisors LLC 55,159$3,993,0000.26%
ISTHMUS PARTNERS, LLC 10,754$779,0000.23%
Cardinal Capital Management 9,180$665,0000.22%
Acrospire Investment Management LLC 1,919$139,0000.13%
Penobscot Investment Management Company, Inc. 4,000$290,0000.09%
TFS CAPITAL LLC 3,226$234,0000.09%
WCM INVESTMENT MANAGEMENT, LLC 81,912$5,930,0000.09%
View complete list of UTAH MED PRODS INC shareholders